Cargando…

Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis

OBJECTIVES: Bempedoic acid (BA) is a novel oral low-density lipoprotein cholesterol lowering drug. This systematic review and meta-analysis aims to assess efficacy and safety for clinical outcomes in high cardiovascular (CV) risk patients. DATA SOURCES: MEDLINE, Cochrane Central Register of Controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yingfeng, Parco, Claudio, Karathanos, Athanasios, Krieger, Torben, Schulze, Volker, Chernyak, Nadja, Icks, Andrea, Kelm, Malte, Brockmeyer, Maximilian, Wolff, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883220/ https://www.ncbi.nlm.nih.gov/pubmed/35210334 http://dx.doi.org/10.1136/bmjopen-2021-048893

Ejemplares similares

Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
por: Brockmeyer, Maximilian, et al.
Publicado: (2022)

National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort
por: Parco, Claudio, et al.
Publicado: (2021)

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
por: Wolff, Georg, et al.
Publicado: (2022)

Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
por: Pradhan, Akshyaya, et al.
Publicado: (2023)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
por: Biolo, Gianni, et al.
Publicado: (2022)

Untangling the relationship between bempedoic acid and gout: results from a systematic literature review
por: Alunno, Alessia, et al.
Publicado: (2023)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
por: Tummala, Ramyashree, et al.
Publicado: (2022)

Bempedoic Acid: The New Kid on the Block for the Treatment of Dyslipidemia and LDL Cholesterol: A Narrative Review
por: Alam, Uazman, et al.
Publicado: (2021)

THU584 Comparison Of The Cardiovascular Benefits Of Bempedoic Acid With Statins- Analysis By The Cholesterol Treatment Trialists’ Methodology
por: Lincoff, A Michael, et al.
Publicado: (2023)

Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
por: Pinkosky, Stephen L., et al.
Publicado: (2016)

Bempedoic acid for the treatment of dyslipidemia
por: Marrs, Joel C, et al.
Publicado: (2020)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Case report: Strong low-density-cholesterol reduction accompanied by shrinkage of low-attenuation coronary plaque during lipid-lowering treatment with bempedoic acid—serial evaluation by coronary computed tomography angiography
por: Korosoglou, Grigorios, et al.
Publicado: (2023)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
por: Ballantyne, Christie M., et al.
Publicado: (2022)

Dynamic mitral regurgitation caused by exercise-induced left bundle branch abnormality and unmasked by isometric handgrip testing
por: Spieker, Maximilian, et al.
Publicado: (2023)

Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)

Bempedoic acid: what prospective uses?
por: Jacomelli, Ilaria, et al.
Publicado: (2023)

Pre-test of questions on health-related resource use and expenditure, using behaviour coding and cognitive interviewing techniques
por: Chernyak, Nadja, et al.
Publicado: (2012)

Pharmacokinetics of bempedoic acid in patients with renal impairment
por: Amore, Benny M., et al.
Publicado: (2021)

Correction to: Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)

An Update on New Cholesterol Inhibitor: Bempedoic Acid
por: Kulshreshtha, Mayank
Publicado: (2022)

Severe Hypertriglyceridemia After Use of Bempedoic Acid
por: Bovy, Valentin, et al.
Publicado: (2023)

Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
por: Katzmann, Julius L., et al.
Publicado: (2022)

Right ventricular dysfunction assessed by cardiovascular magnetic resonance is associated with poor outcome in patients undergoing transcatheter mitral valve repair
por: Spieker, Maximilian, et al.
Publicado: (2021)

Bempedoic acid: A nonstatin drug for the management of hypercholesterolemia
por: Govindaraju, Asvitha, et al.
Publicado: (2021)

Quantified patient preferences for lifestyle intervention programs for diabetes prevention—a protocol for a systematic review
por: Dintsios, Charalabos-Markos, et al.
Publicado: (2018)

Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy
por: Mottola, Giorgio, et al.
Publicado: (2023)

Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
por: Wolff, Georg, et al.
Publicado: (2020)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
por: Hiremath, Jagdish, et al.
Publicado: (2023)

Left atrial appendage sizing for percutaneous closure in virtual reality—a feasibility study
por: Heidari, Houtan, et al.
Publicado: (2023)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date
por: McCormack, Terry, et al.
Publicado: (2016)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
por: Bilen, Ozlem, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m57iadqgk92nikeeo9r60p38f0